# Management of Iron Deficiency Anemia in Hemodialysis Patients

Study · id `cardio:ct-nct07706582` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07706582](<https://clinicaltrials.gov/study/NCT07706582>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07706582

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 108 participants.

## Technical summary

Registry record NCT07706582. Randomized; no masking; primary purpose treatment. Start 2025-11-02 (actual); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 108 participants (enrolled count; ClinicalTrials.gov record NCT07706582, source copy `cardio:ctgov-nct07706582-2026-10-30`, retrieved 2026-10-31)
- Started: 2025-11-02 (actual) (ClinicalTrials.gov record NCT07706582, source copy `cardio:ctgov-nct07706582-2026-10-30`, retrieved 2026-10-31)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT07706582, source copy `cardio:ctgov-nct07706582-2026-10-30`, retrieved 2026-10-31)
- Completion: 2027-03 (anticipated) (ClinicalTrials.gov record NCT07706582, source copy `cardio:ctgov-nct07706582-2026-10-30`, retrieved 2026-10-31)
- Countries: Egypt (ClinicalTrials.gov record NCT07706582, source copy `cardio:ctgov-nct07706582-2026-10-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07706582-2026-10-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Management of Iron Deficiency Anemia in Hemodialysis Patients
- Condition: Iron Deficiency Anemia (IDA)
- Condition: ESRD (End Stage Renal Disease)
- Intervention (Dietary supplement): Lactoferrin
- Intervention (Drug): IV iron sucrose
- Lead sponsor: Beni-Suef University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Beni-Suef University (`cardio:org-beni-suef-university`)

## Provenance

Content hash: 186717191baa25107a5802e22653e6e81a7bafc8aa57fd839856b8b7d5564070
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
